These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Risk of subacute sclerosing panencephalitis from measles vaccination. Halsey N. Pediatr Infect Dis J; 1990 Nov 06; 9(11):857-8. PubMed ID: 2263442 [No Abstract] [Full Text] [Related]
23. Analysis of serum and cerebrospinal fluid cytokine levels in subacute sclerosing panencephalitis in Papua New Guinea. Ichiyama T, Siba P, Suarkia D, Reeder J, Takasu T, Miki K, Maeba S, Furukawa S. Cytokine; 2006 Jan 07; 33(1):17-20. PubMed ID: 16413199 [Abstract] [Full Text] [Related]
24. Surveillance of subacute sclerosing panencephalitis. Bellman MH, Dick G. Br Med J; 1980 Aug 02; 281(6236):393-4. PubMed ID: 7427296 [No Abstract] [Full Text] [Related]
25. Measles, mumps, rubella vaccine induced subacute sclerosing panencephalitis. Belgamwar RB, Prasad S, Appaya P. J Indian Med Assoc; 1997 Nov 02; 95(11):594. PubMed ID: 9567594 [Abstract] [Full Text] [Related]
26. Measles vaccination and risk of SSPE. Agarwal RK. Indian Pediatr; 1999 Mar 02; 36(3):317. PubMed ID: 10713848 [No Abstract] [Full Text] [Related]
27. Subacute sclerosing panencephalitis in Northern Ireland: twenty years' experience. Morrow JI, Dowey KE, Swallow MW. Ulster Med J; 1986 Oct 02; 55(2):124-30. PubMed ID: 3811010 [Abstract] [Full Text] [Related]
28. [Reasons for vaccinating against measles]. Celers J, Netter R. Bull Acad Natl Med; 1982 Jun 02; 166(6):801-7. PubMed ID: 6756595 [No Abstract] [Full Text] [Related]
29. "Melanie's measles" is deadly and causes permanent neurologic impairment. Hotez PJ. Microbes Infect; 2018 Feb 02; 20(2):63-64. PubMed ID: 29126876 [No Abstract] [Full Text] [Related]
30. [Subacute sclerosing panencephalitis (SSPE) in Poland in 1996-1999. Phase VII of epidemiologic studies]. Naruszewicz-Lesiuk D, Iwińska-Buksowicz B, Wieczorkiewicz M, Kulczycki J, Gut W. Neurol Neurochir Pol; 2000 Feb 02; 34(5):877-85. PubMed ID: 11253477 [Abstract] [Full Text] [Related]
31. [Epidemiology of subacute sclerosing panencephalitis in Okinawa, Japan, 1970-1996]. Hirayasu K, Nakada Y, Takaesu E, Kamiya K, Hirayama K. No To Hattatsu; 1999 Jan 02; 31(1):27-31. PubMed ID: 10025131 [Abstract] [Full Text] [Related]
32. Subacute sclerosing panencephalitis in South America. Roman G, Navarro L, Toro G, Vergara I. Lancet; 1976 Dec 18; 2(7999):1352-3. PubMed ID: 63819 [No Abstract] [Full Text] [Related]
33. An epidemiological study of subacute sclerosing panencephalitis in Kenya. Tukei PM, Kenya PR, Ensering H. East Afr Med J; 1983 Jan 18; 60(1):34-8. PubMed ID: 6628287 [No Abstract] [Full Text] [Related]
34. Serologic diagnosis of measles in subacute sclerosing panencephalitis. Furesz J. N Engl J Med; 1971 Apr 01; 284(13):729-30. PubMed ID: 5546240 [No Abstract] [Full Text] [Related]
35. [Complications of measles and antimeasles vaccination]. Reinert P, Lemerle S, Kohout G, Bernaudin F. Ann Pediatr (Paris); 1984 Jun 01; 31(6):477-80. PubMed ID: 6147112 [No Abstract] [Full Text] [Related]
36. Subacute sclerosing panencephalitis in a vaccinated, internationally adopted child. Brouns R, Verlinde P, Lagae L, De Koster J, Lemmens F, Van de Casseye W. Acta Neurol Belg; 2001 Jun 01; 101(2):128-30. PubMed ID: 11486561 [No Abstract] [Full Text] [Related]
37. The epidemiology of subacute sclerosing panencephalitis in England and Wales 1990-2002. Miller C, Andrews N, Rush M, Munro H, Jin L, Miller E. Arch Dis Child; 2004 Dec 01; 89(12):1145-8. PubMed ID: 15557053 [Abstract] [Full Text] [Related]
38. [Subacute sclerosing panencephalitis (SSPE) viruses and epidemiology]. Ueda S, Okuno Y. Nihon Rinsho; 1978 May 01; Suppl():1290-1. PubMed ID: 691326 [No Abstract] [Full Text] [Related]